Skip to main content
Premium Trial:

Request an Annual Quote

EPA Taps Cellumen for Second Phase of Toxcast Program

NEW YORK (GenomeWeb News) – Cellumen said today that it will provide analysis services for the second phase of the US Environmental Protection Agency's ToxCast program.

Cellumen said that the work with EPA "could generate" up to $5.5 million for the company, but did not disclose further financial details.

The company has been participating in the ToxCast program since 2007. In the first proof-of-concept phase, Cellumen generated hepatic toxicity data using its CellCiphr platform. Under the expanded agreement, the company will generate CellCiphr profiles for "thousands" of chemicals.

ToxCast is an EPA initiative that aims to reduce the time and costs associated with toxicity testing of chemicals.

Filed under

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more